Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial

Chertow, GM; Correa-Rotter, R; Vart, P; Jongs, N; McMurray, JJV; Rossing, P; Langkilde, AM; Sjöström, CD; Toto, RD; Wheeler, DC; Heerspink, HJL

Heerspink, HJL (通讯作者)，Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, De Brug 50D-1-015,EB70,POB 30001, NL-9700 AD Groningen, Netherlands.

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023; 12 (9):

Abstract

BACKGROUND: The DAPA-CKD (Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease) trial (NCT03036150) demonstrated that dapagliflo......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索